Abstract
First Solar will report fiscal first-quarter 2026 results on April 30, 2026, Post Market; this preview highlights consensus expectations for revenue, profitability, and EPS alongside sell-side viewpoints and the operational factors investors are watching most closely.
Market Forecast
Based on the latest consolidated forecast data, First Solar is expected to deliver approximately 1.03 billion US dollars of revenue in the first quarter of 2026, implying year-over-year growth of 23.29%. The current-quarter EPS estimate stands at 2.87, up 14.83% year over year, and EBIT is projected at 303.81 million US dollars with 9.83% growth year over year.
The company’s revenue base remains concentrated in its modules business, and management’s disclosed expansion and technology steps point to shipment execution as the primary driver of near-term outcomes. Within that umbrella, modules continue to be the most promising revenue engine, supported by contracted deliveries and capacity build-out plans; the module segment’s revenue contribution in the reported business breakdown was 5.22 billion US dollars.
Last Quarter Review
In the previous quarter (fiscal Q4 2025), First Solar reported revenue of 1.68 billion US dollars (+11.15% year over year), a gross profit margin of 39.54%, GAAP net profit attributable to shareholders of 0.52 billion US dollars (quarter-on-quarter change +14.24%), a net profit margin of 30.95%, and adjusted EPS of 4.84 (+32.60% year over year).
A key financial highlight was the revenue beat versus estimates alongside a modest EPS shortfall: revenue of 1.68 billion US dollars surpassed the prior estimate by roughly 0.12 billion US dollars, while EPS of 4.84 trailed the prior estimate by 0.31. In terms of business mix, reported breakdowns show revenue concentrated in modules at 5.22 billion US dollars, while quarterly revenue rose 11.15% year over year, signaling healthy shipment and pricing execution into year-end.
Current Quarter Outlook
Main business: Modules revenue, delivery cadence, and margin profile
The core revenue driver remains the sale of modules, and current-quarter expectations hinge on delivery cadence and the associated conversion of backlog into recognized revenue. The forecasts point to approximately 1.03 billion US dollars of revenue for Q1 2026, up 23.29% year over year, indicating a strong start to the fiscal year despite typical seasonal patterns. Within the profit stack, the EBIT projection of 303.81 million US dollars translates to 9.83% year-over-year growth, and the current EPS estimate of 2.87 anticipates double-digit expansion compared with the prior-year quarter.
Gross margin and net margin forecasts are not formally enumerated in the consolidated projections, but last quarter’s gross margin of 39.54% and net margin of 30.95% established a high base into year-end. The step-down from Q4 EPS of 4.84 to a Q1 estimate of 2.87 reflects the normalizing seasonality from a stronger year-end quarter and the quarter-specific mix of deliveries in early 2026. The quarter-on-quarter vector should therefore be interpreted in the context of shipment phasing, ramp costs on new lines, and the mix of contracted ASPs in the recognized revenue set.
Execution priorities for the modules business this quarter include sustaining on-time contractual deliveries and maintaining cost discipline to protect the spread between average selling prices and unit costs. Mix and timing effects can sway the realized margin profile within the quarter, especially if more deliveries cluster toward projects with differing contractual terms. With revenue growth expected to outpace EBIT growth on a year-over-year basis this quarter, investors are likely to parse gross profit progression carefully against shipment scale.
Most promising business focus: Module capacity expansion and technology roadmap
The company’s near-term growth narrative within its mainstay modules franchise centers on capacity additions and technology steps that are designed to lift throughput and underpin delivery schedules. Management and third-party commentary this year referenced a new 3.70 GW module manufacturing line in South Carolina, with production expected to commence in the fourth quarter of 2026 and volume ramp through 2027; while this facility does not contribute to Q1 2026 revenue, it frames a key pathway for medium-term shipment growth and cost leverage. In parallel, a February agreement provided US market licensing access to Oxford PV’s current and in-process patents, supporting the company’s exploration of perovskite-enabled device architectures as part of its broader R&D pathway.
These actions matter for investors now because they influence expectations around long-duration contract economics and future conversion costs, even before incremental output is recognized. The market is likely to view tangible milestones—permitting, tooling, pilot yields, and any early validation steps—through the lens of whether they reinforce or challenge the multi-year volume and margin trajectory. With Q1 revenue projected to increase by 23.29% year over year, the underlying shipment performance this quarter serves as a bridge between the 2025 exit run-rate and the coming capacity-led phases, anchoring confidence in the roadmap.
While the current-quarter forecast does not itemize a segment-level revenue breakout, the module line remains the practical locus of growth potential, and investors are tracking whether the quarterly revenue trend aligns with the company’s throughput expectations and the pace of contract conversions. For Q1, that translates into a focus on whether recognized revenue and EPS land near the 1.03 billion US dollars and 2.87 markers, respectively, and how that performance updates expectations for the rest of 2026.
Key stock-price swing factors this quarter
Three forces are most likely to shape share-price reactions around the print and guide: shipment execution versus the revenue and EPS benchmarks, updated commentary on 2026 cost and tariff headwinds, and any fresh datapoints on mid-2026 capacity and technology updates. Revenue of about 1.03 billion US dollars and EPS of 2.87 imply healthy year-over-year growth, but investors typically scrutinize any gap against consensus and management’s qualitative color on the next quarter’s delivery pipeline. A clean delivery quarter with stable costs would tend to reduce volatility; conversely, timing shifts or higher-than-expected unit costs could pressure the margin narrative.
Several brokers this year highlighted tariff-related volume and margin considerations at international facilities as an area to watch, along with the translation of policy tailwinds into realized pricing. Management commentary earlier in the year flagged that tariff-related impacts for 2026 are non-trivial; how that risk is being managed will be relevant to near-term gross margin expectations. The EBIT growth estimate of 9.83% year over year in Q1 suggests growth, yet the leverage implied is less than the revenue growth rate, making cost lines—materials, overhead, and ramp expenses—an area investors will parse carefully.
Finally, while the South Carolina facility and technology licensing developments are medium-term, any updates on schedule, capex cadence, or early technical validation could recalibrate forward margin expectations and the embedded assumptions in price targets. In the near term, the company’s commentary about contracted ASPs, the phasing of deliveries through mid-2026, and the balance of domestic and international production will inform whether the path for full-year EPS remains on track with the early-year run-rate. Given the higher base from Q4 2025 and the expected seasonal normalization into Q1, the market will also look for indications of improving momentum into Q2 as shipments and cost efficiency typically scale through the year.
Analyst Opinions
Bullish views dominate recent coverage in our collection window, comprising approximately 90% of directional calls versus roughly 10% bearish, with several well-known institutions reiterating Buy or Overweight stances and adjusting targets within a tight range. Barclays reiterated a Buy with a 279.00 US dollars target, and J.P. Morgan maintained a Buy at 256.00 US dollars, emphasizing continued confidence through 2026 despite a normalization from the seasonally strong Q4 base. Morgan Stanley maintained an Overweight rating while recalibrating its price target to 230.00 US dollars in March, framing the adjustment as a function of updated medium-term assumptions rather than a thesis change; in the same period, Susquehanna kept a Positive rating at 250.00 US dollars, and Guggenheim reiterated Buy with a 269.00 US dollars target. Mizuho maintained Outperform with a 271.00 US dollars target, keeping the name among its favored ideas for 2026 given the revenue and earnings trajectory implied by contracted deliveries and capacity execution.
The bullish case ties directly to the current-quarter setup: forecasts imply revenue growth of 23.29% year over year and double-digit EPS expansion, which—if achieved or exceeded—would help sustain confidence in the full-year glide path. Analysts with favorable views also note that the EPS transition from 4.84 in Q4 2025 to a 2.87 estimate in Q1 2026 should be interpreted through the lens of quarter-to-quarter shipment phasing and mix, rather than as a deterioration in the underlying earnings power. In practice, Sell-side models that remain constructive tend to focus on whether cost lines move in line with plan and whether revenue timing supports re-acceleration into Q2 and Q3 as deliveries ramp through the middle of the year.
Price-target discipline across bullish houses appears anchored in a moderately narrower band than in prior quarters, reflecting both sensitivity to tariff- and cost-related risks and confidence in the company’s ability to deliver contracted volumes. Barclays’ 279.00 US dollars and Guggenheim’s 269.00 US dollars targets cluster just above the mid-200s, while Mizuho’s 271.00 US dollars sits at the upper end of the recent re-based target set; Morgan Stanley’s 230.00 US dollars is on the conservative end of the bullish spectrum but keeps the positive stance intact. The common thread is that module revenue progression and the translation of capacity investments into throughput underpin the forward margin framework; as long as Q1 results substantiate the 23.29% revenue growth guidepost and the profitability profile implied by the 303.81 million US dollars EBIT estimate, these targets look internally consistent with the near-term trajectory.
Bullish analysts also highlight how incremental technology steps and announced capacity enhance the visibility of shipment growth in 2026–2027, even if those elements do not directly contribute to Q1 revenue. The licensing arrangement for perovskite-related intellectual property is framed as a forward-looking enabler for device architecture improvements, a view that supports the longer-term earnings construct within positive models. Commentary around the South Carolina ramp, slated to begin contributing in late 2026 with volumes building in 2027, is being treated as a medium-term accelerant; in the interim, execution against existing capacity and delivery commitments is the focal point for quarterly results.
In short, the prevailing analyst view expects the company to post year-over-year revenue and EPS growth in Q1 consistent with the 1.03 billion US dollars and 2.87 benchmarks, respectively, and to provide an update that maintains confidence in shipment, cost, and margin progress through the middle of 2026. If the company demonstrates stable gross profit conversion from shipments and confirms that tariff and cost pressures are being managed within existing guardrails, bullish targets in the mid-200s appear compatible with the current cadence. Conversely, should revenue timing slip or costs expand faster than modeled, the shares could face near-term volatility; however, such scenarios are minority positions within recent published opinions, leaving the bullish camp as the clear majority heading into April 30, 2026, Post Market.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments